Tissue Net Borrowings vs Begin Period Cash Flow Analysis

TRX Stock   58.50  1.50  2.50%   
Tissue Regenix financial indicator trend analysis is much more than just breaking down Tissue Regenix Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tissue Regenix Group is a good investment. Please check the relationship between Tissue Regenix Net Borrowings and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Net Borrowings vs Begin Period Cash Flow

Net Borrowings vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tissue Regenix Group Net Borrowings account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak relationship.
The correlation between Tissue Regenix's Net Borrowings and Begin Period Cash Flow is 0.39. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Tissue Regenix Group, assuming nothing else is changed. The correlation between historical values of Tissue Regenix's Net Borrowings and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Tissue Regenix Group are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Borrowings i.e., Tissue Regenix's Net Borrowings and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.39
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Tissue Regenix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tissue Regenix Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
As of January 7, 2025, Selling General Administrative is expected to decline to about 10.2 M. In addition to that, Tax Provision is expected to decline to about (14.5 K)

Tissue Regenix fundamental ratios Correlations

0.93-0.420.450.550.480.19-0.370.520.570.44-0.12-0.560.450.260.47-0.190.260.330.240.370.360.380.590.360.42
0.93-0.220.160.310.180.15-0.40.320.320.15-0.44-0.260.240.550.22-0.440.550.10.420.080.180.10.780.330.12
-0.42-0.22-0.7-0.79-0.790.520.03-0.32-0.62-0.81-0.450.77-0.230.29-0.6-0.340.29-0.110.14-0.84-0.9-0.88-0.060.3-0.73
0.450.16-0.70.870.960.150.050.480.830.960.7-0.930.65-0.560.80.47-0.560.63-0.380.940.720.92-0.160.10.97
0.550.31-0.790.870.94-0.09-0.080.650.940.90.63-0.930.56-0.50.880.36-0.50.6-0.080.870.760.88-0.110.240.86
0.480.18-0.790.960.94-0.02-0.080.570.890.990.73-0.950.57-0.580.880.51-0.580.57-0.390.970.790.96-0.170.110.98
0.190.150.520.15-0.09-0.02-0.080.160.07-0.05-0.05-0.060.440.05-0.01-0.10.050.52-0.03-0.09-0.43-0.210.060.520.07
-0.37-0.40.030.05-0.08-0.08-0.080.0-0.05-0.060.150.05-0.07-0.19-0.170.03-0.190.150.12-0.03-0.060.03-0.26-0.33-0.05
0.520.32-0.320.480.650.570.160.00.810.50.37-0.60.25-0.320.610.24-0.320.630.120.410.340.43-0.080.430.48
0.570.32-0.620.830.940.890.07-0.050.810.850.62-0.890.58-0.520.90.41-0.520.73-0.10.770.640.8-0.150.390.83
0.440.15-0.810.960.90.99-0.05-0.060.50.850.72-0.940.56-0.570.850.53-0.570.51-0.440.980.820.98-0.170.030.99
-0.12-0.44-0.450.70.630.73-0.050.150.370.620.72-0.670.49-0.980.750.73-0.980.59-0.520.710.50.71-0.80.170.74
-0.56-0.260.77-0.93-0.93-0.95-0.060.05-0.6-0.89-0.94-0.67-0.650.53-0.85-0.50.53-0.630.24-0.91-0.74-0.90.13-0.17-0.93
0.450.24-0.230.650.560.570.44-0.070.250.580.560.49-0.65-0.440.650.28-0.440.77-0.130.50.20.48-0.210.520.63
0.260.550.29-0.56-0.5-0.580.05-0.19-0.32-0.52-0.57-0.980.53-0.44-0.67-0.721.0-0.580.47-0.55-0.36-0.550.9-0.22-0.59
0.470.22-0.60.80.880.88-0.01-0.170.610.90.850.75-0.850.65-0.670.47-0.670.67-0.280.760.640.79-0.340.480.83
-0.19-0.44-0.340.470.360.51-0.10.030.240.410.530.73-0.50.28-0.720.47-0.720.35-0.540.520.450.52-0.6-0.030.53
0.260.550.29-0.56-0.5-0.580.05-0.19-0.32-0.52-0.57-0.980.53-0.441.0-0.67-0.72-0.580.47-0.55-0.36-0.550.9-0.22-0.59
0.330.1-0.110.630.60.570.520.150.630.730.510.59-0.630.77-0.580.670.35-0.58-0.010.440.070.4-0.370.640.56
0.240.420.14-0.38-0.08-0.39-0.030.120.12-0.1-0.44-0.520.24-0.130.47-0.28-0.540.47-0.01-0.46-0.25-0.420.390.24-0.48
0.370.08-0.840.940.870.97-0.09-0.030.410.770.980.71-0.910.5-0.550.760.52-0.550.44-0.460.810.98-0.16-0.110.96
0.360.18-0.90.720.760.79-0.43-0.060.340.640.820.5-0.740.2-0.360.640.45-0.360.07-0.250.810.87-0.02-0.220.75
0.380.1-0.880.920.880.96-0.210.030.430.80.980.71-0.90.48-0.550.790.52-0.550.4-0.420.980.87-0.17-0.110.96
0.590.78-0.06-0.16-0.11-0.170.06-0.26-0.08-0.15-0.17-0.80.13-0.210.9-0.34-0.60.9-0.370.39-0.16-0.02-0.17-0.19-0.2
0.360.330.30.10.240.110.52-0.330.430.390.030.17-0.170.52-0.220.48-0.03-0.220.640.24-0.11-0.22-0.11-0.190.07
0.420.12-0.730.970.860.980.07-0.050.480.830.990.74-0.930.63-0.590.830.53-0.590.56-0.480.960.750.96-0.20.07
Click cells to compare fundamentals

Tissue Regenix Account Relationship Matchups

Tissue Regenix fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets36.7M34.1M38.3M43.2M49.7M30.2M
Total Stockholder Equity28.5M25.4M26.0M30.2M34.7M25.9M
Liabilities And Stockholders Equity36.7M34.1M38.3M43.2M49.7M30.3M
Other Stockholder Equity93.5M98.1M138.9M154.4M177.5M186.4M
Total Liab8.9M9.5M13.0M13.9M16.0M16.8M
Common Stock11.7M11.8M13.3M91K104.7K99.4K
Common Stock Shares Outstanding44.5M70.3M70.3M70.4M81.0M80.5M
Other Current Liab1.4M477.5K4.4M2.6M3.0M1.6M
Total Current Liabilities3.3M3.2M5.5M4.7M5.4M5.7M
Property Plant And Equipment Net5.7M6.7M7.4M9.0M10.4M10.9M
Net Debt(4.2M)175.7K3.0M4.7M5.5M5.7M
Retained Earnings(77.7M)(84.7M)(96.8M)(123.8M)(111.4M)(105.8M)
Accounts Payable1.3M2.6M1.1M1.2M1.4M921.0K
Cash9.6M5.7M4.9M4.7M4.2M4.0M
Non Current Assets Total16.6M17.8M20.0M24.2M27.8M29.2M
Non Currrent Assets Other(8.6M)(8.6M)(9.6M)(5.2M)(6.0M)(6.3M)
Cash And Short Term Investments9.6M5.7M4.9M4.7M4.2M4.0M
Net Receivables3.5M3.4M4.3M2.4M2.7M2.1M
Good Will8.6M8.6M9.6M11.6M10.4M9.1M
Non Current Liabilities Total5.6M6.3M7.5M9.2M10.5M11.1M
Other Current Assets1.7M1.2M834.7K4.1M4.7M4.9M
Property Plant And Equipment Gross5.7M9.1M8.9M14.4M16.6M17.4M
Total Current Assets20.1M16.3M18.3M19.1M22.0M20.8M
Accumulated Other Comprehensive Income955K197.9K(942.7K)(529.5K)(608.9K)(639.4K)
Intangible Assets10.9M11.1M12.5M3.5M4.1M3.9M
Property Plant Equipment2.4M5.7M9.1M8.9M10.3M10.8M
Net Tangible Assets7.2M17.7M19.3M17.6M20.2M17.7M
Inventory7.1M7.2M9.0M10.4M11.9M12.5M
Other Liab670K560K640K520K468K618.7K
Net Invested Capital31.3M38.8M37.5M36.1M41.6M38.4M
Net Working Capital16.8M17.7M15.4M14.4M16.5M15.8M
Capital Stock9.6M9.2M9.2M91K81.9K77.8K
Short Long Term Debt Total5.3M5.9M8.0M9.4M10.8M6.8M
Long Term Debt2.8M4.5M5.3M5.5M6.4M4.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tissue Stock

Balance Sheet is a snapshot of the financial position of Tissue Regenix Group at a specified time, usually calculated after every quarter, six months, or one year. Tissue Regenix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tissue Regenix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tissue currently owns. An asset can also be divided into two categories, current and non-current.